Unnamed: 0,title,date,stock,sentiment
426481.0,"The Daily Biotech Pulse: Soleno Flunks Late-Stage Study, Sanofi Strikes Breast Cancer Partnership, NanoViricides Shortlists Coronavirus Treatment Candidates",2020-06-09 07:46:00-04:00,ENZ,negative
426482.0,"Enzo Biochem Q3 EPS $(0.21) Down From $(0.14) YoY, Sales $17.00M Miss $20.92M Estimate",2020-06-08 16:06:00-04:00,ENZ,negative
426483.0,"Earnings Scheduled For June 8, 2020",2020-06-08 04:04:00-04:00,ENZ,neutral
426484.0,"The Week Ahead In Biotech: Viela FDA Decision, Hematology Conference Take Center Stage",2020-06-07 13:43:00-04:00,ENZ,neutral
426485.0,Enzo Biochem Reports Launch Of Proprietary Test For Detection Of Coronavirus Antibody Under FDA Emergency Use Authorization,2020-05-20 08:20:00-04:00,ENZ,negative
426486.0,Enzo Announces Issuance Of US Patent For Methods Of Producing Monoclonal Antibodies Against Osteoporosis Drug Target Sclerostin,2020-05-12 08:07:00-04:00,ENZ,neutral
426487.0,Enzo Biochem Reports Issuance Of US Patent For Methods Of Using Proprietary Compound SK1-I in Patients; Exploring Options for Development as a Potential Treatment for COVID-19,2020-04-29 08:00:00-04:00,ENZ,neutral
426488.0,82 Biggest Movers From Yesterday,2020-04-29 04:30:00-04:00,ENZ,neutral
426489.0,76 Biggest Movers From Yesterday,2020-04-24 04:42:00-04:00,ENZ,neutral
426490.0,Why Enzo Biochem Shares Are Rallying,2020-04-23 13:22:00-04:00,ENZ,positive
426491.0,54 Stocks Moving In Thursday's Mid-Day Session,2020-04-23 12:24:00-04:00,ENZ,neutral
426492.0,Mid-Morning Market Update: Markets Open Higher; Eli Lilly Beats Q1 Views,2020-04-23 10:15:00-04:00,ENZ,neutral
426493.0,Enzo Biochem Highlights Launch Of Proprietary Coronavirus Diagnostic Test Under FDA's Emergency Use Authorization,2020-04-23 08:03:00-04:00,ENZ,negative
426494.0,"Enzo Biochem Says Saw Material Decline In Laboratory Testing Volumes Due To Coronavirus As Patients Reduced Office Visits, Decline Expected To Continue Through Remainder Of Q3, Expects Covid-19 Related Products And Services To Partially Offset Decline",2020-04-09 16:54:00-04:00,ENZ,neutral
426495.0,Enzo Biochem Subsidiary Launches Drive Through Facility To Provide Coronavirus Testing On Long Islant,2020-03-24 07:48:00-04:00,ENZ,neutral
426496.0,"The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates",2020-03-18 07:36:00-04:00,ENZ,positive
426497.0,90 Biggest Movers From Yesterday,2020-03-12 06:10:00-04:00,ENZ,neutral
426498.0,78 Stocks Moving In Wednesday's Mid-Day Session,2020-03-11 12:12:00-04:00,ENZ,neutral
426499.0,108 Biggest Movers From Yesterday,2020-03-11 05:34:00-04:00,ENZ,neutral
426500.0,82 Stocks Moving In Tuesday's Mid-Day Session,2020-03-10 12:25:00-04:00,ENZ,neutral
426501.0,Mid-Morning Market Update: Markets Open Higher; Dicks Sporting Goods Earnings Beat Expectations,2020-03-10 10:17:00-04:00,ENZ,neutral
426502.0,"Enzo Biochem, Precision Drilling, WPX Energy Shares Halted On Circuit Breakers",2020-03-10 09:36:00-04:00,ENZ,positive
426503.0,"The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index",2020-03-10 09:19:00-04:00,ENZ,negative
426504.0,123 Biggest Movers From Yesterday,2020-03-10 05:57:00-04:00,ENZ,neutral
426505.0,20 Healthcare Stocks Moving In Monday's Session,2020-03-09 13:40:00-04:00,ENZ,neutral
426506.0,101 Stocks Moving In Monday's Mid-Day Session,2020-03-09 12:00:00-04:00,ENZ,neutral
426507.0,Mid-Morning Market Update: Markets Open Lower; Oil Drops 20% Following Saudi-Russia Price War,2020-03-09 10:11:00-04:00,ENZ,negative
426508.0,52 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-03-09 08:04:00-04:00,ENZ,neutral
426509.0,38 Stocks Moving in Monday's Pre-Market Session,2020-03-09 07:19:00-04:00,ENZ,neutral
426510.0,100 Biggest Movers From Friday,2020-03-09 05:25:00-04:00,ENZ,neutral
426511.0,4 Biotech Stocks Moving On COVID-19 Updates,2020-03-06 15:48:00-05:00,ENZ,neutral
426512.0,Mid-Afternoon Market Update: Dow Falls 600 Points; American Outdoor Brands Shares Slide On Downbeat Results,2020-03-06 14:21:00-05:00,ENZ,positive
426513.0,Mid-Day Market Update: Crude Oil Plunges 7.5%; Digirad Shares Spike Higher,2020-03-06 12:40:00-05:00,ENZ,negative
426514.0,60 Stocks Moving In Friday's Mid-Day Session,2020-03-06 12:11:00-05:00,ENZ,neutral
426515.0,"Mid-Morning Market Update: Markets Open Lower; U.S. Adds 273,000 Jobs For February",2020-03-06 10:20:00-05:00,ENZ,negative
426516.0,"The Daily Biotech Pulse: Breakthrough Device Designation For Neuronetics, AbbVie Receives European Label Expansion, AstraZeneca Flunks Late-Stage Study",2020-03-06 08:49:00-05:00,ENZ,negative
426517.0,Enzo Biochem's Full-Service Clinical Laboratory to Launch Coronavirus Testing Services Next Week,2020-03-06 08:01:00-05:00,ENZ,neutral
426518.0,"Enzo Biochem Q2 EPS $(0.16) Up From $(0.18) YoY, Sales $19.384M Miss $20.92M Estimate",2020-03-05 16:08:00-05:00,ENZ,negative
426519.0,Stocks That Hit 52-Week Lows On Friday,2020-02-28 10:16:00-05:00,ENZ,negative
426520.0,Stocks That Hit 52-Week Lows On Thursday,2020-02-27 10:23:00-05:00,ENZ,negative
426521.0,"The Daily Biotech Pulse: Moderna Ships COVID-19 Vaccine For Clinics, Mallinckrodt Strikes $1.6B Opioid Settlement",2020-02-25 08:28:00-05:00,ENZ,negative
426522.0,Enzo Biochem Highlights Publication Of Study Detailing Promising Activity Of Drug Candidate SK1â€‘I In A Model Of Lupus,2020-02-19 08:48:00-05:00,ENZ,positive
426523.0,Stocks That Hit 52-Week Lows On Tuesday,2020-02-18 11:11:00-05:00,ENZ,negative
426524.0,"The Daily Biotech Pulse: Deciphera Cancer Drug Gets Priority Review, Fast Track Designation For Soligenix, Revolution Medicines IPO",2020-02-13 08:05:00-05:00,ENZ,negative
426525.0,Stocks That Hit 52-Week Lows On Wednesday,2020-02-12 11:50:00-05:00,ENZ,negative
426526.0,"The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data",2020-02-12 09:18:00-05:00,ENZ,positive
426527.0,Enzo Biochem Announces NY State Department Of Health Approval For Tests On Co.'s GenFlex Program,2020-02-11 08:37:00-05:00,ENZ,positive
426528.0,"The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology",2020-02-11 07:23:00-05:00,ENZ,positive
426529.0,"Enzo Biochem Reports Harbert Discovery Fund Filed Suit Against Co., Board; Co. Provides Response",2020-02-07 08:04:00-05:00,ENZ,neutral
426530.0,Enzo Offers Comment On Harbert Reaction To Providing Co. Shareholders Added Choices,2020-01-30 08:17:00-05:00,ENZ,neutral
426531.0,"Harbert Discovery Fund Issues Press Release On Enzo Biochem, Suggests Co. 'Acted Out of Desperation to Undermine the Will of its Shareholders,' Says Intends To Pursue All Available Options To Ensure Shareholder Voices Are Heard",2020-01-29 10:56:00-05:00,ENZ,negative
426532.0,Hedge Fund Harbert Discovery Sends a Letter to Enzo Biochem Shareholders,2020-01-27 06:50:00-05:00,ENZ,neutral
426533.0,21 Diagnostics & Research Stocks Moving In Thursday's Session,2020-01-23 12:53:00-05:00,ENZ,neutral
426534.0,Harbert Discovery Fund Issues Press Release Highlighting Glass Lewis Has Recommended Vote for Election Of Firm Nominees To Enzo Biochem Board,2020-01-16 13:12:00-05:00,ENZ,positive
426535.0,Enzo Biochem Responds to Statements From Activist Hedge Fund Harbert,2020-01-13 08:09:00-05:00,ENZ,neutral
426536.0,Stocks That Hit 52-Week Lows On Friday,2020-01-10 12:24:00-05:00,ENZ,negative
426537.0,"The Daily Biotech Pulse: Positive Data Readouts To Spur Aclaris, Moderna And Ultragenyx",2020-01-10 07:13:00-05:00,ENZ,positive
426538.0,Stocks That Hit 52-Week Lows On Thursday,2020-01-09 15:17:00-05:00,ENZ,negative
426539.0,Enzo Biochem Stakeholder Harbert Discovery Fund Sends Letter To Shareholders Encouraging Them To Vote For Fund's Board Nominees,2019-12-30 09:01:00-05:00,ENZ,positive
426540.0,"Enzo Biochem Board To Consider Alternatives For Co.'s Therapeutics Subsidiary, Including Spin Off, Sale, Joint Venture Or License Of IP",2019-12-10 16:42:00-05:00,ENZ,neutral
426541.0,"Enzo Biochem Q1 EPS $(0.16) Down From $(0.13) YoY, Sales $20.207M Miss $20.92M Estimate",2019-12-10 16:16:00-05:00,ENZ,negative
426542.0,"The Daily Biotech Pulse: ASH Meeting Wraps, Fast Track Designation For Equillium, Pfizer To Buy $3M In ContraFect Shares",2019-12-10 07:56:00-05:00,ENZ,positive
426543.0,"Earnings Scheduled For December 10, 2019",2019-12-10 04:43:00-05:00,ENZ,neutral
426544.0,Enzo Biochem Sends Letter To Shareholders; Notes 'Short-Term Activist' Harbert Seeking Fire Sale Of Co. At 'Depressed Prices'; Urges Vote 'For' On White Proxy Card,2019-12-05 16:26:00-05:00,ENZ,negative
426545.0,"Enzo Biochem In Letter Urges Shareholders To Vote For Board's Nominees, Criticizes Board Nominees By Activist Harbert",2019-12-05 16:19:00-05:00,ENZ,negative
426546.0,"Enzo Biochem Q4 EPS $(0.11) Up From $(0.12) YoY, Sales $20.921M Beat $19.66M Estimate",2019-10-15 16:18:00-04:00,ENZ,neutral
426547.0,64 Biggest Movers From Yesterday,2019-10-15 05:07:00-04:00,ENZ,neutral
426548.0,New York State Health Department Approves Enzo Clinical Labs Hepatitis B Virus Quantitative Clinical Assay,2019-09-24 09:09:00-04:00,ENZ,positive
426549.0,35 Healthcare Stocks Moving In Wednesday's After-Market Session,2019-07-25 05:55:00-04:00,ENZ,neutral
426550.0,Enzo Biochem Announces 3 Transformative Initiatives,2019-07-11 09:04:00-04:00,ENZ,neutral
426551.0,66 Biggest Movers From Yesterday,2019-06-12 04:44:00-04:00,ENZ,neutral
426552.0,Enzo Biochem shares are trading higher after the company reported better-than-expected Q3 EPS and sales results.,2019-06-11 15:51:00-04:00,ENZ,positive
426553.0,"Enzo Biochem Q3 Adj. EPS $(0.14) Beats $(0.15) Estimate, Sales $22.3M Beat $19.31M Estimate",2019-06-10 16:18:00-04:00,ENZ,neutral
426554.0,"Earnings Scheduled For June 10, 2019",2019-06-10 06:39:00-04:00,ENZ,neutral
426555.0,50 Biggest Movers From Yesterday,2019-05-22 05:12:00-04:00,ENZ,neutral
426556.0,Enzo Biochem Inc. Announces Issuance Of United States Patent For Treatment Of Liver Cancer Using Ozanimod,2019-05-10 10:48:00-04:00,ENZ,negative
426557.0,"UPDATE: Enzo To Receive $14M In 1-Time Payments 'in exchange for fully paid-up, worldwide licenses to Hologic and Grifols'",2019-04-22 11:59:00-04:00,ENZ,neutral
426558.0,"Enzo Biochem 8-K Shows Co.'s Life Sciences Subsidiary Entered Settlement, License Deal With Hologic, Grifols To Settle All Outstanding Patent Disputes Among Parties",2019-04-22 11:59:00-04:00,ENZ,positive
426559.0,71 Biggest Movers From Yesterday,2019-03-28 05:01:00-04:00,ENZ,neutral
426560.0,60 Stocks Moving In Wednesday's Mid-Day Session,2019-03-27 13:08:00-04:00,ENZ,neutral
426561.0,31 Stocks Moving In Wednesday's Pre-Market Session,2019-03-27 08:39:00-04:00,ENZ,neutral
426562.0,56 Biggest Movers From Yesterday,2019-03-13 06:04:00-04:00,ENZ,neutral
426563.0,"Enzo Biochem Q2 EPS $(0.18) Misses $(0.13) Estimate, Sales $19.327M Miss $21.01M Estimate",2019-03-11 16:17:00-04:00,ENZ,negative
426564.0,"Earnings Scheduled For March 11, 2019",2019-03-11 04:17:00-04:00,ENZ,neutral
426565.0,Enzo Biochem 8-K Shows Co. Entered Into Settlement With Roche; Enzo Agreed To Pay $21M In Settlement Pursuant To Agreement,2019-02-11 11:52:00-05:00,ENZ,positive
426566.0,"The Daily Biotech Pulse: Tracon Aces Early-Stage Trials, Boston Scientific To Buy Out Millipede",2018-12-27 07:51:00-05:00,ENZ,neutral
426567.0,"The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial",2018-12-21 07:58:00-05:00,ENZ,neutral
426568.0,"Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 20, 2018",2018-12-20 11:33:00-05:00,ENZ,negative
426569.0,"The Daily Biotech Pulse: Tilray Inks Cannabis Drink Pact, Double Delight For Merck, FDA Snub For Spectrum",2018-12-20 07:53:00-05:00,ENZ,positive
426570.0,"Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 18, 2018",2018-12-19 12:43:00-05:00,ENZ,negative
426571.0,"The Daily Biotech Pulse: Pfizer-Glaxo Set Up Consumer Health Care Venture, New Patent For Adamas",2018-12-19 07:46:00-05:00,ENZ,positive
426572.0,"The Daily Biotech Pulse: Puma Aces Late-Stage Trial, Chinese Cheer For FibroGen, J&J $5B Buyback Plan",2018-12-18 08:00:00-05:00,ENZ,positive
426573.0,"Stocks Which Set New 52-Week Low Last Trading Session, Fri., Dec. 14, 2018",2018-12-17 11:48:00-05:00,ENZ,negative
426574.0,"Stocks Which Set New 52-Week Low Yesterday, Thurs., Dec. 13, 2018",2018-12-14 11:03:00-05:00,ENZ,negative
426575.0,48 Biggest Movers From Yesterday,2018-12-12 05:14:00-05:00,ENZ,neutral
426576.0,"The Daily Biotech Pulse: Management Change At Merck, Jazz Buyback, Arrowhead Earnings",2018-12-11 08:22:00-05:00,ENZ,neutral
426577.0,"Enzo Biochem, Inc. Q1 EPS $(0.13) Misses $(0.11) Estimate, Sales $21.26M Beat $21.12M Estimate",2018-12-10 16:16:00-05:00,ENZ,negative
426578.0,"Earnings Scheduled For December 10, 2018",2018-12-10 04:54:00-05:00,ENZ,neutral
426579.0,60 Biggest Movers From Yesterday,2018-12-07 04:42:00-05:00,ENZ,neutral
426580.0,44 Stocks Moving In Thursday's Mid-Day Session,2018-12-06 13:49:00-05:00,ENZ,neutral
426581.0,Enzo Biochem Highlights Publication Of Study On SK1-I Detailing Promising Results In Model Of Treatment-Resistance Breast Cancer,2018-12-03 09:03:00-05:00,ENZ,negative
426582.0,"Stocks Which Set New 52-Week Low Yesterday, Mon., Nov. 19, 2018",2018-11-20 09:12:00-05:00,ENZ,negative
426583.0,"The Daily Biotech Pulse: Denali's Positive Results, Novartis' Substance Abuse Therapy Launch, Medtronic Earnings",2018-11-20 08:29:00-05:00,ENZ,negative
426584.0,"Stocks Which Set New 52-Week Low Friday, October 26th",2018-10-29 09:56:00-04:00,ENZ,negative
426585.0,"The Daily Biotech Pulse: AbbVie Takes Full Control Of Cystic Fibrosis Program, Amgen Slashes Cholesterol Drug Price",2018-10-25 08:03:00-04:00,ENZ,negative
426586.0,58 Biggest Movers From Yesterday,2018-10-23 05:09:00-04:00,ENZ,neutral
426587.0,"Enzo Biochem Director Perlysky Buys 10,000 @ Avg Price: $3.50",2018-10-22 12:53:00-04:00,ENZ,neutral
426588.0,"The Daily Biotech Pulse: Novartis Positive Liver Drug Trials, Krytstal Prices Offering, LogicBio To Debut",2018-10-19 08:28:00-04:00,ENZ,positive
426589.0,"The Daily Biotech Pulse: Eiger's Lymphoedema Drug Study Fails, Roche's Sales Rise",2018-10-17 08:15:00-04:00,ENZ,negative
426590.0,"The Daily Biotech Pulse: Enzo's Q4 Loss, Sanofi's Positive Trial Results, ImmunoCellular To Delist",2018-10-16 08:52:00-04:00,ENZ,positive
426591.0,"Stocks Which Set New 52-Week Low Yesterday, October 11th",2018-10-12 11:30:00-04:00,ENZ,negative
426592.0,"The Daily Biotech Pulse: FDA Thumbs Down For Trevena, Corium To Go Private, Immune Design Discontinues Cancer Vaccine Program",2018-10-12 07:34:00-04:00,ENZ,negative
426593.0,"Stocks Which Set New 52-Week Low Friday, October 5th",2018-10-08 09:27:00-04:00,ENZ,negative
426594.0,"Stocks Which Set New 52-Week Low Yesterday, September 24th",2018-09-25 09:16:00-04:00,ENZ,negative
426595.0,"The Daily Biotech Pulse: Syndax Lung Cancer Trial Disappoints, Gemphire To Trim Workforce, Opiant's Offering",2018-09-25 08:30:00-04:00,ENZ,negative
426596.0,Enzo Biochem Acquires New Manufacturing And Distribution Facility For $6M,2018-08-27 08:31:00-04:00,ENZ,neutral
426597.0,"Stocks Which Set New 52-Week Low Yesterday, August 8th",2018-08-09 11:10:00-04:00,ENZ,negative
426598.0,"The Daily Biotech Pulse: Ampio Slides On Offering, Sangamo's Positive Trial Results, Insys Earnings",2018-08-09 08:39:00-04:00,ENZ,positive
426599.0,"Stocks Which Set New 52-Week Low Yesterday, August 7th",2018-08-08 11:06:00-04:00,ENZ,negative
426600.0,"The Daily Biotech Pulse: FDA Panel Backs Insmed, Eidos' Maiden Earnings, Paratek Awaits Adcom Verdict",2018-08-08 08:15:00-04:00,ENZ,positive
426601.0,"Stocks Which Set New 52-Week Low Friday, July 27",2018-07-30 12:17:00-04:00,ENZ,negative
426602.0,"Stocks Which Set New 52-Week Low Yesterday, July 25th",2018-07-26 11:19:00-04:00,ENZ,negative
426603.0,"Stocks Which Set New 52-Week Lows Yesterday, July 24th:",2018-07-25 12:17:00-04:00,ENZ,negative
426604.0,"Benzinga's Daily Biotech Pulse: Merck's Keytruda Found Effective, Nabriva To Acquire Zavante, FDA Denies Agile",2018-07-25 08:41:00-04:00,ENZ,positive
426605.0,"Benzinga's Daily Biotech Pulse: Celgene's Lymphoma Trial Meets Endpoint, Merit Medical's Strong Q2, Bluebird Bio Offering",2018-07-24 08:53:00-04:00,ENZ,positive
426606.0,Stocks Which Set New 52-Week Lows Friday,2018-07-23 11:11:00-04:00,ENZ,negative
426607.0,"Benzinga's Daily Biotech Pulse: Novartis Licenses Skin Drug, 2 Stocks To Debut",2018-07-19 09:14:00-04:00,ENZ,neutral
426608.0,"Benzinga's Daily Biotech Pulse: Gemphire On Fire, Acceleron-Celgene Taste Success, AbbVie Ditches Galapagos",2018-06-29 08:11:00-04:00,ENZ,positive
426609.0,"Benzinga's Daily Biotech Pulse: Eli Lilly, Edge Therapeutics, BioXcel Report Positive Trial Results, 4 Stocks Debut",2018-06-28 08:26:00-04:00,ENZ,positive
426610.0,"Benzinga's Daily Biotech Pulse: FDA Greenlights Tandem Diabetes' Insulin Pump, More IPOs On Tap",2018-06-22 08:51:00-04:00,ENZ,neutral
426611.0,42 Biggest Movers From Yesterday,2018-06-13 05:31:00-04:00,ENZ,neutral
426612.0,Mid-Afternoon Market Update: Enzo Biochem Falls After Q3 Results; Galmed Pharmaceuticals Shares Surge,2018-06-12 14:32:00-04:00,ENZ,positive
426613.0,Mid-Day Market Update: RH Rises On Earnings Beat; Griffon Shares Plunge,2018-06-12 12:41:00-04:00,ENZ,positive
426614.0,41 Stocks Moving In Tuesday's Mid-Day Session,2018-06-12 12:29:00-04:00,ENZ,neutral
426615.0,Mid-Morning Market Update: Markets Mostly Higher; Lands' End Posts Upbeat Q1 Results,2018-06-12 10:16:00-04:00,ENZ,neutral
426616.0,"Benzinga's Daily Biotech Pulse: Galmed Rips Higher On Positive NASH Data, Enzo Biochem Falls On Earnings, Pfenex Licenses Osteoporosis Candidate",2018-06-12 08:47:00-04:00,ENZ,positive
426617.0,7 Stocks Moving In Monday's After-Hours Session,2018-06-11 17:20:00-04:00,ENZ,neutral
426618.0,"Enzo Biochem Q3 EPS $(0.06) Misses $(0.02) Estimate, Sales $25.63M Miss $27.92M Estimate",2018-06-11 16:13:00-04:00,ENZ,negative
426619.0,"Earnings Scheduled For June 11, 2018",2018-06-11 04:05:00-04:00,ENZ,neutral
426620.0,"Enzo Biochem Reports Enzo Life Sciences Unit Denied Petition Filed BY Hologic For PTAB Against US Patent 6,221,581",2018-04-24 10:01:00-04:00,ENZ,negative
426621.0,Earnings Outlook For Enzo Biochem,2018-03-13 08:04:00-04:00,ENZ,neutral
426622.0,"Earnings Scheduled For March 13, 2018",2018-03-13 05:20:00-04:00,ENZ,neutral
426623.0,"Enzo Biochem Reports Q2 EPS $(0.02) vs $(0.01) Est., Sales $27M vs $27.35M Est.",2018-03-12 16:16:00-04:00,ENZ,neutral
426624.0,Enzo Biochem Announces New Validated Cost-Effective Cervical Cancer Biomarker Detection Test,2018-01-22 09:05:00-05:00,ENZ,negative
426625.0,"Enzo Biochem Reports Q1 Adj. EPS $(0.01) In-line With Est., Sales $27.7M vs $27.48M Est.",2017-12-07 16:27:00-05:00,ENZ,neutral
426626.0,"Earnings Scheduled For December 7, 2017",2017-12-07 04:55:00-05:00,ENZ,neutral
426627.0,Enzo Biochem Reports NYS Dept. Of Health Approved A New Women's Health Infectious Disease Panel,2017-10-23 08:39:00-04:00,ENZ,positive
426628.0,18 Biggest Mid-Day Losers For Thursday,2017-09-28 13:09:00-04:00,ENZ,negative
426629.0,"Enzo Biochem Reports Q4 EPS $(0.04) vs $(0.02) Est., Sales $28.2M vs $27.4M Est.",2017-09-27 16:06:00-04:00,ENZ,neutral
426630.0,"Earnings Scheduled For September 27, 2017",2017-09-27 05:44:00-04:00,ENZ,neutral
426631.0,Enzo Biochem Files For $150M Mixed Shelf Offering,2017-09-01 16:58:00-04:00,ENZ,neutral
426632.0,"U.S. District Court Judge Enters Order in Enzo Life Sciences, Inc. v. Abbott Laboratories, Denying Summary Judgement that 405 Patent is Invalid",2017-08-16 06:10:00-04:00,ENZ,negative
426633.0,25 Stocks Moving In Wednesday's Pre-Market Session,2017-08-02 08:14:00-04:00,ENZ,neutral
426634.0,"Enzo Biochem Reports Delaware Court Ruling Denying Summary Judgment That US Patent '180 Is Invalid For Lack Of Written Description, But Granting Summary Judgment That '180 Patent Is Invalid For Lack Of Establishment",2017-06-29 08:02:00-04:00,ENZ,negative
426638.0,Mid-Afternoon Market Update: NASDAQ Down 2.5%; DuPont Fabros Shares Spike Higher,2017-06-09 14:56:00-04:00,ENZ,positive
426639.0,15 Biggest Mid-Day Gainers For Friday,2017-06-09 12:38:00-04:00,ENZ,neutral
426640.0,"Enzo Biochem Reports Q3 Net Income Break-even, Saels $27.1M vs $27.5M Est.",2017-06-08 16:11:00-04:00,ENZ,neutral
426641.0,Enzo Biochem Reports New York State Health Department Approval of New Women's Health Diagnostics,2017-06-08 16:00:00-04:00,ENZ,positive
426642.0,"Earnings Scheduled For June 8, 2017",2017-06-08 04:27:00-04:00,ENZ,neutral
426643.0,Hearing Agora Financial Is Out Positive On Enzo Biochem,2017-05-19 14:17:00-04:00,ENZ,positive
426644.0,"Enzo Biochem Reports Q2 Adj. EPS $(0.02) vs $(0.04) Est., Sales $26.3M vs $26.1M Est.",2017-03-13 16:08:00-04:00,ENZ,neutral
426645.0,"Earnings Scheduled For December 8, 2016",2016-12-08 03:49:00-05:00,ENZ,neutral
426646.0,Mid-Afternoon Market Update: Enzo Biochem Rises Following Q4 Results; Natural Health Trends Shares Decline,2016-10-14 14:51:00-04:00,ENZ,positive
426647.0,12 Biggest Mid-Day Gainers For Friday,2016-10-14 12:46:00-04:00,ENZ,neutral
426648.0,Mid-Day Market Update: Advanced Micro Devices Climbs After Chip Deal With Alibaba; Ocean Power Technologies Shares Slide,2016-10-14 12:20:00-04:00,ENZ,positive
426649.0,Mid-Morning Market Update:  Markets Open Higher; Citigroup Profit Tops Expectations,2016-10-14 10:28:00-04:00,ENZ,positive
426650.0,18 Stocks Moving In Friday's Pre-Market Session,2016-10-14 08:37:00-04:00,ENZ,neutral
426651.0,"Enzo Biochem Reports Q4 non-GAAP EPS $0.04 vs $0.06 Est, Revenue $26.6M vs $26M Est",2016-10-13 16:07:00-04:00,ENZ,neutral
426652.0,"Earnings Scheduled For October 13, 2016",2016-10-13 04:02:00-04:00,ENZ,neutral
426653.0,16 Stocks Moving In Monday's Pre-Market Session,2016-10-10 08:42:00-04:00,ENZ,neutral
426654.0,Enzo Biochem Reports NY State Health Dept. Approval of PLAQPRO Lp-PLA Assay,2016-09-20 12:25:00-04:00,ENZ,positive
426655.0,Enzo Biochemical Files For $50M Mixed Shelf Offering,2016-09-01 17:10:00-04:00,ENZ,neutral
426656.0,"Enzo Biochem's Life Sciences Unit Reaches $21 Million Patent Infringement Settlement in Delaware With Illumina, Inc.",2016-07-07 09:15:00-04:00,ENZ,negative
426657.0,"8-K from Enzo Biochem Shows Subsidiary, Enzo Life Sciences, Reached, Finalized Settlement Deal with Illumina, Includes $21M Payment to Co.",2016-07-07 08:07:00-04:00,ENZ,positive
426658.0,Mid-Morning Market Update: Markets Open Higher; Lululemon Reports Mixed Q1 Results,2016-06-08 10:14:00-04:00,ENZ,neutral
426659.0,"Enzo Biochem Reports Q3 GAAP EPS $(0.05), Non-GAAP EPS $(0.04) vs. Est. $(0.06), Rev. $26.43M vs. Est. $24.5M",2016-06-08 07:30:00-04:00,ENZ,neutral
426660.0,"Earnings Scheduled For June 8, 2016",2016-06-08 04:54:00-04:00,ENZ,neutral
426661.0,"Enzo Biochem's Life Sciences Unit Reaches $35M Patent Infringement Settlement in Delaware With Life Technologies Corporation, 7 Suits Remain Pending",2016-05-16 16:08:00-04:00,ENZ,negative
426662.0,"Enzo Biochem Reports Q2 EPS $0.15 vs $(0.09) in Same Qtr. Last Year, Sales $24.6M vs $24.4M Est.",2016-03-09 16:09:00-05:00,ENZ,neutral
426663.0,"Earnings Scheduled For March 9, 2016",2016-03-09 04:07:00-05:00,ENZ,neutral
426664.0,"Enzo Biochem Reaches $9M Patent Infringement Settlement with Agilent Technologies, Inc.",2016-01-06 08:31:00-05:00,ENZ,negative
426665.0,"Enzo Issues Comment on Lone Star's Decision to Withdraw Proxy Contest: Says Grateful to Holders for Continued Dialogue, Input, Support",2015-12-30 09:00:00-05:00,ENZ,positive
426666.0,"UPDATE: Lone Star Value Withdraws Proxy Contest, Says Will Monitor Enzo for Any Failure to Deliver",2015-12-29 09:04:00-05:00,ENZ,negative
426667.0,"Lone Star Value Issues Statement To Fellow Enzo Shareholders, Responds to Flaws in ISS Report and Enzo's False Allegations",2015-12-29 09:00:00-05:00,ENZ,positive
426668.0,Enzo Biochem Issues Release Showing Glass Lewis Supports Co. Nominees for Board,2015-12-23 11:11:00-05:00,ENZ,positive
426669.0,UPDATE: Enzo Letter Urges Holders to Vote White Proxy Card FOR Co.'s Nominees,2015-12-22 12:30:00-05:00,ENZ,neutral
426670.0,"UPDATE: Enzo Calls Lone Star's Nominees 'Unqualified, Conflicted, and Lack Any Plan for Creating Shareholder Value'",2015-12-22 12:29:00-05:00,ENZ,positive
426671.0,"UPDATE: Enzo Biochem Says Believes Activist Lone Star's Claims, Misleading Assertions Show Clear Lack of Understanding of Co.'s Business",2015-12-22 12:28:00-05:00,ENZ,negative
426672.0,UPDATE: Enzo Biochem Issues Open Letter to Shareholders,2015-12-22 12:26:00-05:00,ENZ,neutral
426673.0,Enzo Biochem Sends Open Letter to Holders,2015-12-22 12:26:00-05:00,ENZ,neutral
426674.0,"Lone Star Value Issues Open Letter to Shareholders of Enzo Biochem, Inc.",2015-12-22 09:01:00-05:00,ENZ,positive
426675.0,Enzo Biochem Reports Inline Q1 EPS $(0.05),2015-12-07 16:16:00-05:00,ENZ,neutral
426676.0,Mid-Morning Market Update: Markets Edge Higher; Wal-Mart Profit Beats Expectations,2015-11-17 10:09:00-05:00,ENZ,positive
426677.0,Enzo Biochem Announces $10M Patent Infringement Settlement with Affymetrix,2015-10-13 08:03:00-04:00,ENZ,negative
426678.0,"Enzo Bipharma Reports Inline Q4 Loss $0.06, Revs $25.7M Vs Est $24.60M",2015-10-13 07:31:00-04:00,ENZ,negative
426679.0,"Earnings Scheduled For October 13, 2015",2015-10-13 04:01:00-04:00,ENZ,neutral
426680.0,"Wedbush Analyst Upgrades Luminex After Quarterly Results, New CEO",2015-08-04 08:56:00-04:00,ENZ,neutral
426681.0,Enzo Biochem Settles On Patent Infringement Action Fro $7.1M,2015-07-06 10:00:00-04:00,ENZ,negative
426682.0,"Enzo Biochem Reports Q3 Loss of $0.06/Share, Inline, Sales $23.986M vs $24.4M Est.",2015-06-09 16:16:00-04:00,ENZ,negative
426683.0,8-K from Enzo Biochem Shows Co. Requested Hearing by Federal Circuit Court Related to Appeals Court Decision from Mar. 16,2015-04-16 16:14:00-04:00,ENZ,neutral
426684.0,"Dyax Corp, BioCryst Pharma Lead Tuesday's After-Hours Movers",2015-03-31 19:40:00-04:00,ENZ,neutral
426685.0,"Amarin, LeapFrog Lead Monday's After-Hours Movers",2015-03-16 17:44:00-04:00,ENZ,neutral
426686.0,Enzo Biochem Reports Request for Rehearing of Appeals Court Decision,2015-03-16 11:40:00-04:00,ENZ,neutral
426687.0,US Appeals Court Rules in Favor of Applera vst Enzo Biochem in Patent Infringement Case -Reuters,2015-03-16 11:23:00-04:00,ENZ,negative
426688.0,Hearing Life's Applera Has Won Appeal Overturning Enzo's Patent Verdict,2015-03-16 09:41:00-04:00,ENZ,positive
426689.0,Enzo Biochem Receives NYS Approval of First FlowScript Assay for Improved Detection of Cervical Cancer Progression,2015-03-13 07:37:00-04:00,ENZ,positive
426690.0,Enzo Biochem Announces New Novel Platform,2015-02-10 10:04:00-05:00,ENZ,positive
426691.0,"Earnings Scheduled For December 9, 2014",2014-12-09 05:23:00-05:00,ENZ,neutral
426692.0,"Enzo Biochem, Inc. Reports Q4 EPS of $(0.06) vs $(0.07) Est; Revenue of $24.90M vs $23.60M Est",2014-10-09 16:16:00-04:00,ENZ,neutral
426693.0,"Earnings Scheduled For October 9, 2014",2014-10-09 05:33:00-04:00,ENZ,neutral
426694.0,"Enzo Biochem Awarded Patent for Novel Vectors Involving Gene Therapy Treatments for Cancer, Virus Infections and Genetic Diseases ",2014-10-07 09:05:00-04:00,ENZ,negative
426695.0,Enzon Biochem To Receive $7M From PerkinElmer in Lawsuit Settlement,2014-06-23 07:32:00-04:00,ENZ,negative
426696.0,Enzo Announces Collaboration with Inna To Support Novel Application of ProteoStat Products,2014-05-30 08:32:00-04:00,ENZ,positive
426697.0,Enzo Biochem Announces $5.1M Settlement Agreement with Affymetrix,2014-04-24 09:50:00-04:00,ENZ,positive
426698.0,"Enzo Biochem, Inc. Reports Q2 EPS of $(0.09) vs $(0.08) Est; Revenue of $22.90M vs $22.0M Est",2014-03-11 16:20:00-04:00,ENZ,neutral
426699.0,Enzo Biochem Shares Spikes Lower,2014-02-27 14:32:00-05:00,ENZ,neutral
426700.0,"Craig-Hallum Initiates Coverage on Enzo Biochem, Inc. at Buy, Announces $5.50 PT",2014-02-04 11:03:00-05:00,ENZ,neutral
426701.0,UPDATE: Federal Court Awards Enzo Biochem over $61M in Patent Infringement Damages Against Life Technologies,2014-01-06 10:42:00-05:00,ENZ,negative
426702.0,Federal Court Awards Enzo Biochem Over $61M In Patent Infringement Damages,2014-01-06 10:40:00-05:00,ENZ,negative
426703.0,"Enzo Biochem, Inc. Reports Q1 EPS of $(0.07)",2013-12-10 16:33:00-05:00,ENZ,neutral
426704.0,"Enzo Biochem, Inc. Reports Q3 EPS of $(0.08), Up 47% YOY; Revenue of $23.30M",2013-10-15 16:30:00-04:00,ENZ,neutral
426705.0,Enzo Biochem Expecting Prejudgement Interest on Damages Exceeding $25M,2013-08-05 12:14:00-04:00,ENZ,neutral
426706.0,Court Upholds $48.6M Jury Award to Enzo Biochem,2013-08-05 12:08:00-04:00,ENZ,positive
426707.0,"UPDATE: Apollo Group to Replace Forest Oil In S&P Midcap 400, Forest Oil to Replace Enzo Biochem In S&P 600 Smallcap Index",2013-06-20 17:19:00-04:00,ENZ,neutral
426708.0,"Enzo Biochem, Inc. Enters into $8.0M Senior Secured Revolving Credit Facility with Healthcare Finance Group",2013-06-11 07:15:00-04:00,ENZ,positive
426709.0,"Enzo Biochem, Inc. Reports Q3 EPS of $(0.15); Revenue of $22.60M",2013-06-10 16:34:00-04:00,ENZ,neutral
426710.0,"Earnings Scheduled For December 10, 2012",2012-12-10 02:02:00-05:00,ENZ,neutral
426711.0,Enzo Biochem Shares Halted with News Pending,2012-11-01 15:51:00-04:00,ENZ,positive
426712.0,Enzo Biochem Reports Q4 EPS $-0.69; Revenues $26.41M,2012-10-15 16:17:00-04:00,ENZ,neutral
426713.0,"Earnings Scheduled For October 15, 2012",2012-10-15 02:04:00-04:00,ENZ,neutral
426714.0,Earnings Scheduled For June 11,2012-06-11 04:13:00-04:00,ENZ,neutral
426715.0,Enzo Biochem Announces Expanded Distribution Agreement with Japan's Cosmo Bio   ,2012-03-20 07:01:00-04:00,ENZ,positive
426716.0,A Peek Into The Market Before The Trading Starts,2012-03-13 07:18:00-04:00,ENZ,neutral
426717.0,Enzo Biochem's Clinical Laboratory Applies for NY State Health Department Approval for First Assay Based on Its AmpiProbe,2012-03-13 07:02:00-04:00,ENZ,positive
426718.0,Earnings Scheduled For March 12,2012-03-12 04:45:00-04:00,ENZ,neutral
426719.0,Enzo Biochem Receives Approval for Novel Blood Based Test for Colorectal Cancer Risk   ,2012-02-21 08:37:00-05:00,ENZ,negative
426720.0,"Enzo Life Sciences Sues Roche, Life Technologies, Gen-Probe Alleging Infringement of Patent for Gene Analysis",2012-02-02 09:36:00-05:00,ENZ,negative
426721.0,Enzo Q1 EPS $(0.12) vs $(0.08) Est; Revenue $25.8M vs $27.04M Est,2011-12-12 16:18:00-05:00,ENZ,neutral
426722.0,Rodman & Renshaw Lowers PT On Enzo Biochem to $5,2011-10-18 14:07:00-04:00,ENZ,negative
426723.0,"Laboratory Corp. of America Holdings Earnings Preview: Analysts Expect Higher EPS, Revenue",2011-10-17 10:08:00-04:00,ENZ,neutral
426724.0,Enzo Biochem Reports Q4 EPS $(0.11) vs $(0.03) Est; Revenues $26.8M vs 27.6M Est,2011-10-14 16:11:00-04:00,ENZ,neutral
426725.0,Earnings Scheduled For October 12,2011-10-12 04:22:00-04:00,ENZ,neutral
426726.0,"Laboratory Corporation of America Holdings Earnings Preview: Analyts Expect Higher Earnings, Revenue from Prior Quarter",2011-07-18 14:55:00-04:00,ENZ,neutral
426727.0,Rodman & Renshaw Reiterates Market Outperform and PT of $7 on Enzo Biochem,2011-07-07 05:57:00-04:00,ENZ,neutral
426728.0,Enzo Scientists Report on Key Discovery of Novel Targets for Metabolic Bone Disease and Other Conditions ,2011-07-06 08:04:00-04:00,ENZ,positive
426729.0,Rodman & Renshaw Provides Color on Enzo Biochem,2011-06-22 05:53:00-04:00,ENZ,neutral
426730.0,U.S. Supreme Court Declines Life Technologies Appeal Hearing in Patent Infringement Suit Brought by Enzo Biochem Claiming Substantial Damages,2011-06-21 11:01:00-04:00,ENZ,negative
426731.0,Rodman & Renshaw Outperform On Enzo Biochem ,2011-06-10 12:22:00-04:00,ENZ,neutral
426732.0,"Rodman & Renshaw Reiterates Enzo Biochem Market Outperform, $7 PT",2011-06-10 12:13:00-04:00,ENZ,neutral
426733.0,Enzo Biochem's Clinical Lab Acquires Marketing Rights to More Effective Diagnostic Test for Cervical Cancer   ,2011-06-10 07:31:00-04:00,ENZ,negative
426734.0,Enzo Biochem Report EPS of $(0.05) vs. $(0.11) Estimate; Revenues $25.8M vs. $24.77M Estimate,2011-06-09 16:46:00-04:00,ENZ,neutral
426735.0,Enzo Biochem Reports Q2 EPS of $(0.15) vs. $(0.10),2011-03-14 16:33:00-04:00,ENZ,neutral
426736.0,Enzo Biochem Reports Q1 Loss ,2010-12-13 07:29:00-05:00,ENZ,negative
426737.0,Enzo Biochem Reports Mixed Earnings (ENZ),2010-10-14 16:14:00-04:00,ENZ,neutral
426738.0,Enzo Biochem Reports Fourth Quarter Results,2010-10-14 16:11:00-04:00,ENZ,neutral
426739.0,"Earnings Scheduled For October 14 (GOOG, GWW, AMD, FCS, SWY, JBHT, CBST, ENZ, LSTR, HRLY)",2010-10-14 05:24:00-04:00,ENZ,neutral
426740.0,Enzo Biochem Expects Positive Operating Cash Flow in 2011 (ENZ),2010-09-20 15:51:00-04:00,ENZ,positive
426741.0,"Top 5 Percentage Gainers On NYSE (DV, CKH, ENZ, LAD, CMG)",2010-07-23 15:18:00-04:00,ENZ,positive
426742.0,US Board Of Patent Appeals Denies Siemens Rehearing On Enzo Patent,2010-05-17 11:10:00-04:00,ENZ,negative
